No CrossRef data available.
Article contents
1452 – Perimenopausal Depression: a Review
Published online by Cambridge University Press: 15 April 2020
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction
From adolescence, women have a 1.5 to 3 times higher risk than men of suffering from a depressive disorder. This risk increases in middle-aged of the life and even more in the transition period to menopause or perimenopause, when the depressive vulnerability becomes especially intense.
Objectives
To know more about depression in perimenopause.
Aims
To provide practitioners with accurate information about this condition thus helping to better recognition and treatment.
Methods
a selective literature review on the topic is performed.
Results
Hormonal, psychological and sociocultural factors have been suggested to understand the etiopathogeny of this condition. Treatment of depression in perimenopause is determined by the clinical severity and includes antidepressants, psychotherapy, and sometimes, hormone replacement therapy with estrogens.
Conclusions
Perimenopausal depression is an underdiagnosed and poorly treated problem, which generates a high level of suffering and deserves greater attention by clinicians and health systems.
- Type
- Abstract
- Information
- European Psychiatry , Volume 28 , Issue S1: Abstracts of the 21th European Congress of Psychiatry , 2013 , 28-E770
- Copyright
- Copyright © European Psychiatric Association 2013
You have
Access
Comments
No Comments have been published for this article.